Catheter-related infection control received continued attention through evidence examining both pharmacologic and procedural approaches. A meta-analysis suggested taurolidine-containing catheter locks were associated with fewer catheter-related bloodstream infections in children, while also noting that the data were insufficient to establish comparative safety. In another infection-adjacent update, a study assessed adherence to microaspiration-prevention practices in ICUs and found training and unit size patterns linked to implementation scores. Together, these results underscore that infection outcomes are shaped both by device-adjacent therapeutics and by how consistently preventive protocols are executed. For the field, the immediate takeaway is operational: even promising adjunctive measures may underperform without standardized training and audit-ready workflows. The evidence base still needs higher-quality comparative trials for safety and clearer thresholds for clinical deployment.